Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2018 BSH指南：套细胞淋巴瘤的管理

2018-05-16 英国血液病学学会 Br J Haematol. 2018 May 16.

套细胞淋巴瘤

2018年5月，英国血液病学学会(BSH)发布了套细胞淋巴瘤的管理指南，指南主要目的是面向临床医生针对套细胞淋巴瘤患者的管理提出指导建议，该指南是对2012年指南的更新，新版指南涵盖了套细胞淋巴瘤的新的治疗观点，涉及移植数据，病理学进展尤其是分子病理学和PET/CT在肿瘤分期和治疗反应评估中的应用。

中文标题：

2018 BSH指南：套细胞淋巴瘤的管理

英文标题：

Guideline for the management of mantle cell lymphoma.

发布机构：

英国血液病学学会

发布日期：

2018-05-16

简要介绍：

2018年5月，英国血液病学学会(BSH)发布了套细胞淋巴瘤的管理指南，指南主要目的是面向临床医生针对套细胞淋巴瘤患者的管理提出指导建议，该指南是对2012年指南的更新，新版指南涵盖了套细胞淋巴瘤的新的治疗观点，涉及移植数据，病理学进展尤其是分子病理学和PET/CT在肿瘤分期和治疗反应评估中的应用。 

拓展指南：与套细胞淋巴瘤相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 BSH指南：套细胞淋巴瘤的管理)] GetToolGuiderByIdResponse(projectId=1, id=82c7b1c0015936de, title=2018 BSH指南：套细胞淋巴瘤的管理, enTitle=Guideline for the management of mantle cell lymphoma., guiderFrom=Br J Haematol. 2018 May 16., authorId=null, author=, summary=2018年5月，英国血液病学学会(BSH)发布了套细胞淋巴瘤的管理指南，指南主要目的是面向临床医生针对套细胞淋巴瘤患者的管理提出指导建议，该指南是对2012年指南的更新，新版指南涵盖了套细胞淋巴瘤的新的治疗观点，涉及移植数据，病理学进展尤其是分子病理学和PET/CT在肿瘤分期和治疗反应评估中的应用。 , cover=, journalId=null, articlesId=null, associationId=1339, associationName=英国血液病学学会, associationIntro=, copyright=0, guiderPublishedTime=Wed May 16 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年5月，英国血液病学学会(BSH)发布了套细胞淋巴瘤的管理指南，指南主要目的是面向临床医生针对套细胞淋巴瘤患者的管理提出指导建议，该指南是对2012年指南的更新，新版指南涵盖了套细胞淋巴瘤的新的治疗观点，涉及移植数据，病理学进展尤其是分子病理学和PET/CT在肿瘤分期和治疗反应评估中的应用。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>套细胞淋巴瘤</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=6a6301c001505ea4" title="套细胞淋巴瘤诊断与治疗中国专家共识（2016版）解读" target=_blank>套细胞淋巴瘤诊断与治疗中国专家共识（2016版）解读</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=5af671c0013080e4" title="2016 套细胞淋巴瘤诊断与治疗中国专家共识" target=_blank>2016 套细胞淋巴瘤诊断与治疗中国专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=c30611c0011089fc" title="2014 ESMO临床实践指南：新诊断和复发性套细胞淋巴瘤的诊断、治疗及随访" target=_blank>2014 ESMO临床实践指南：新诊断和复发性套细胞淋巴瘤的诊断、治疗及随访</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E5%A5%97%E7%BB%86%E8%83%9E%E6%B7%8B%E5%B7%B4%E7%98%A4" target=_blank>有关套细胞淋巴瘤更多指南</a></ul>, tagList=[TagDto(tagId=4848, tagName=套细胞淋巴瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6870, appHits=169, showAppHits=0, pcHits=5157, showPcHits=2368, likes=125, shares=7, comments=14, approvalStatus=1, publishedTime=Sat May 19 22:52:44 CST 2018, publishedTimeString=2018-05-16, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat May 19 22:52:44 CST 2018, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 22:02:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 BSH指南：套细胞淋巴瘤的管理)])
2018 BSH指南：套细胞淋巴瘤的管理
下载请点击：
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=325587, encodeId=44f832558ed2, content=兴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 20 11:34:38 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319862, encodeId=38333198624f, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed May 30 06:54:11 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317997, encodeId=957431e997cd, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu May 24 05:26:28 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317974, encodeId=05d131e974d8, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu May 24 00:21:33 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317808, encodeId=909e31e80898, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed May 23 10:08:46 CST 2018, time=2018-05-23, status=1, ipAttribution=)]
    2018-06-20 大爰

    兴

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=325587, encodeId=44f832558ed2, content=兴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 20 11:34:38 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319862, encodeId=38333198624f, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed May 30 06:54:11 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317997, encodeId=957431e997cd, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu May 24 05:26:28 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317974, encodeId=05d131e974d8, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu May 24 00:21:33 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317808, encodeId=909e31e80898, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed May 23 10:08:46 CST 2018, time=2018-05-23, status=1, ipAttribution=)]
    2018-05-30 半夏微凉

    学习了谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=325587, encodeId=44f832558ed2, content=兴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 20 11:34:38 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319862, encodeId=38333198624f, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed May 30 06:54:11 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317997, encodeId=957431e997cd, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu May 24 05:26:28 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317974, encodeId=05d131e974d8, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu May 24 00:21:33 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317808, encodeId=909e31e80898, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed May 23 10:08:46 CST 2018, time=2018-05-23, status=1, ipAttribution=)]
    2018-05-24 大爰

    学习了谢谢分享!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=325587, encodeId=44f832558ed2, content=兴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 20 11:34:38 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319862, encodeId=38333198624f, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed May 30 06:54:11 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317997, encodeId=957431e997cd, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu May 24 05:26:28 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317974, encodeId=05d131e974d8, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu May 24 00:21:33 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317808, encodeId=909e31e80898, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed May 23 10:08:46 CST 2018, time=2018-05-23, status=1, ipAttribution=)]
    2018-05-24 jihuaijun1112

    学习学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=325587, encodeId=44f832558ed2, content=兴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 20 11:34:38 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319862, encodeId=38333198624f, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed May 30 06:54:11 CST 2018, time=2018-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317997, encodeId=957431e997cd, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu May 24 05:26:28 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317974, encodeId=05d131e974d8, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu May 24 00:21:33 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=317808, encodeId=909e31e80898, content=学习了谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed May 23 10:08:46 CST 2018, time=2018-05-23, status=1, ipAttribution=)]
    2018-05-23 半夏微凉

    学习了谢谢分享

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

套细胞淋巴瘤诊断与治疗中国专家共识（2016版）解读

暂未更新 · 2017-08-10

2016 套细胞淋巴瘤诊断与治疗中国专家共识

中华医学会血液学分会白血病淋巴瘤学组 · 2016-09-30

Baidu
map
Baidu
map
Baidu
map